Plain-English translation of NCT06056999 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Doctors often find small spots on the lungs called nodules on CT scans, but it can be hard to tell whether they are harmless or cancerous without invasive procedures like biopsy. This trial is testing a new approach that uses a blood test and artificial intelligence to help identify which nodules are benign and which are malignant, aiming to improve accuracy and potentially avoid unnecessary procedures.
Currently, when lung nodules are found, doctors often need to perform biopsies or surgery to determine if they are cancer. This trial seeks to develop a simpler blood test method that could accurately identify dangerous nodules earlier and help doctors make better decisions about which patients truly need invasive testing.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will have a blood sample drawn, which will be analyzed using mass spectrometry technology to create a metabolic profile. This information, combined with your CT scan images and artificial intelligence analysis, will help the research team develop and test their new method for identifying whether your nodule is benign or malignant. You will be grouped based on how your nodule appears on the CT scan (ground-glass, part-solid, or solid), and the study team will track how accurately this new blood test approach compares to the results of your scheduled biopsy or surgery.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
China
Sponsor
China-Japan Friendship Hospital
Enrollment target
~150 participants
Started
September 2023
Primary completion
January 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Guangying Zhu, doctor
China-Japan Friendship Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.